Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03997448
Title Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nataliya Uboha
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Abemaciclib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.